Article Information
History
- January 12, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Andrea E. Murmann1,*,
- Quan Q. Gao1,
- William Putzbach1,
- Monal Patel1,
- Elizabeth T. Bartom2,
- Calvin Law1,
- Bryan Bridgeman1,
- Siquan Chen7,
- Kaylin M. McMahon3,5,
- C. Shad Thaxton3,4,5,6 and
- Marcus E. Peter1,2,4,*
- 1Division of Hematology/Oncology
- 2Department of Biochemistry and Molecular Genetics
- 3Department of Urology
- 4Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University, Chicago, IL 60611, USA
- 5Simpson Querrey Institute (SQI) for BioNanotechnology, 303 East Superior, Chicago, IL 60611, USA
- 6International Institute for Nanotechnology, Evanston, IL 60208, USA
- 7Cellular Screening Center, Institute for Genomics & Systems Biology, The University of Chicago, Chicago, IL 60637
- ↵*Co-corresponding authors: Marcus Peter and Andrea Murmann, email: m-peter{at}northwestern.edu/amurmann{at}northwestern.edu
Posted January 12, 2018.
Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells
